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II. Abstract 
Purpose: Previous research has demonstrated the potential for preventative health services to 
help address the existing health disparities in Central Appalachia. The Remote Area Medical 
Corps (RAM) Clinic in Wise County, Virginia provides a critical opportunity to understand 
preventative screening rates and factors affecting use for medically underserved patients in the 
region. This thesis contributes to existing regional research by being the first to survey a large, 
regional sample of underserved patients.  
Methods: Over the course of three days, 205 patients were surveyed using questions primarily 
taken from two national health surveys. Patient characteristics and screening rates were 
compared to national data from the US Census and previous analysis of national health surveys. 
In addition, multi-variable model selection was used to identify the best predictors of screening 
use for RAM patients.  
Results: RAM patients overwhelmingly have low rates of preventative screening use according 
to the United States Preventative Screening Task Force Guidelines. On average, patients were 
missing at least a third of the recommended screenings. Colon, breast and cervical cancer 
screening rates fall well below the national averages. Blood pressure, blood cholesterol and lung 
cancer screening use is low. Model selection results show the importance of a healthcare visit 
within the past year, access to a personal provider and a routine checkup.  
Conclusions: Low screening rates combined with the existing mortality disparities and 
established benefits of early screening demonstrate the need and potential of health care reform 
to improve regional preventative services use.    
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III. Introduction 
 During a three day period in July, over two thousand patients received care at the Remote 
Area Medical Volunteer Corps (RAM) Clinic in Wise County, Virginia (1). The RAM Clinic in 
Wise is currently considered the largest medical outreach clinic in the US given the high patient 
volume and short time frame (2).The clinic provides care to medically underserved patients from 
the surrounding counties of Northeast Tennessee, Southwest Virginia and Eastern Kentucky. For 
many of these underserved patients who are uninsured or underinsured, RAM provides a critical 
source of health care. These patients spend hours sleeping in their cars and waiting in lines to 
receive care in tents, converted livestock stalls and mobile van units at the county fairgrounds. 
To date, no prior research has been undertaken to learn from these patients. The clinic’s regional 
scope and high patient volume provide an opportunity to understand the health care needs and 
behavior of underserved patients in the Central Appalachian region.  
 The Appalachian region as a whole suffers significant health disparities in morbidity and 
mortality when compared to the rest of the US and these disparities are highly concentrated in 
Central Appalachia (3-5). Inequalities in cancer, heart disease and stroke mortality are 
particularly evident. Previous research within Appalachia has demonstrated the role of the 
socioeconomic environment, available healthcare system, physical environment and health 
behavior in contributing to the existing disparities (4-18). While health disparities are complex 
and multidimensional (19), I focus on the use of preventative screenings directly connected to 
regional morality disparities: blood pressure, blood cholesterol, colorectal cancer, prostate 
cancer, breast cancer, cervical cancer and lung cancer screenings. In general, preventative 
screenings can detect diseases early when they are easier to treat and can improve health 
outcomes in the long run. Previous research at the national level suggests that the selected 
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preventative screenings could decrease the regional mortality disparities (20-23). As a result, I 
concentrate on understanding preventative screening use for medically underserved patients in 
the region attending the RAM clinic in Wise County.   
 Awareness of preventing screening rates and contributing factors holds important 
implications for future RAM clinics and policy efforts to improve health outcomes in the 
surrounding region. I aim to answer three fundamental questions: 1) Who are the RAM patients 
and how do they compare to the national population in terms of socioeconomic status, healthcare 
access and health needs? 2) What are the preventative screening use rates for RAM patients? 3) 
What barriers are limiting patient’s use of preventative screenings? To do so, I rely on 205 
patient surveys conducted during the Wise Clinic in 2014.   
11 
 
IV. Background 
A. Appalachia 
 Appalachia is a region consisting of 420 counties in 13 states. The region itself is divided 
into subregions composed of contiguous areas with similar characteristics in terms of 
topography, demographics, and economics. Figure 1 displays the region with subregional 
divisions visible.  
 
Figure 1. Subregions in Appalachia. Source: Appalachian Regional Commission, 2009. 
 
Despite the characterization of a singular Appalachia identity, a wide distribution of 
socioeconomic status exists as measured by poverty, education, and employment (24). Figure 2 
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shows the distribution of countywide economic status, and demonstrates that this distribution 
reflects the subregion divisions. Counties at distressed and at-risk economic levels, cluster in the 
region of Eastern Kentucky, Northeast Tennessee and Southwest Virginia.  
 
Figure 2: County economic status. Source: Appalachian Regional Commission, 2009 
Due to this regionalization, I present data, when available, on a subregional level. 
Because the Wise County RAM Clinic is located there, special attention will be given to 
highlight the relevant regional data for Central Appalachia.  
13 
 
B. Appalachian Health Disparities 
The Appalachian region, as a whole, suffers significant health disparities
i
  when 
compared to the rest of the US (3-5). The region has excess mortality in premature deaths (deaths 
of persons ages 35-64) for heart disease, all cancers combined, lung cancer, colorectal cancer, 
chronic obstructive pulmonary disease and diabetes (3). Similar morbidity disparities exist for 
heart disease, cancer, chronic pulmonary disease, stroke and diabetes (3).   
While these health disparities affect the region as a whole, they are concentrated in select 
regions, notably Central Appalachia and areas in the immediate vicinity (3). Premature mortality 
and excess morbidity for heart disease, all cancers combined, lung cancer, diabetes and Chronic 
Obstructive Pulmonary Disease (COPD) all cluster in the Central Appalachian (3). Figure 3 
displays this geographic clustering for all cancers and heart disease.  
   
Figure 3. Premature Cancer and Heart Disease Death Rates, Source: Halverson et al., 2004 
                                                 
i
 The National Institute of Health defines a health disparity as “a significant disparity in the overall rate of disease 
incidence, prevalence, morbidity, mortality, or survival rates in the population as compared to the health status of the 
general population” 
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The striking geographic pattern of premature mortality and morbidity warrants attention to 
identify the potential determinants of these poor health outcomes.   
C. Factors Underlying Health Outcomes 
 Health disparities are complex, dynamic and multidimensional (19). Previous research in 
Appalachia has identified four contributing factors that affect health outcomes: 1) socioeconomic 
environment 2) available healthcare system 3) physical environment and 4) health behavior.  
Indicators of socioeconomic distress, constructed from socioeconomic variables,
ii
 
correlate significantly to poor health outcomes across Appalachian counties (5). Within Central 
Appalachia, poor socioeconomic conditions correlate to all-cause mortality, heart disease 
mortality and cancer mortality (4). Though low socioeconomic status is one of the most critical 
predictors of poor health outcomes (25-27), socioeconomic variables do not explain the full 
picture. Regions in Appalachia with similar socioeconomic conditions do not necessarily 
experience similar health outcomes (4).  
 The available health care system also affects health outcomes in the region. In 2004, 318 
of 420 Appalachian counties were classified as health professional shortage areas by the Federal 
Health Resources and Services Administration (6, 28). In addition to a lack of available 
healthcare system resources, social distance
iii
 between health care providers and Appalachian 
populations affect accessibility of the health care system (6). This social distance results largely 
from education and income differences between the two groups, but is also due to the fact that 
many health professionals come from outside the area.  
                                                 
ii
 Poverty, income levels, employment status, and education level were all used, individually or combined, to 
measure socioeconomic status (1) (Halverson, 2004). 
iii
 Social distance refers to differences in socioeconomic backgrounds that create barriers in communication between 
individuals.  
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The physical environment also correlates to health outcomes, most importantly with 
regards to coal mining. Environmental “riskscape” models that incorporate socioeconomic and 
environmental stressors such as education outcomes and carcinogens from coal production 
demonstrate a relationship between the physical environment and health outcomes (7, 8).   
Health behavior, a behavior or life choice that impacts an individual’s health status, also 
shapes regional health outcomes (9). Smoking and cancer screening rates have previously 
received the most attention in Appalachia (9). Both behaviors pose challenges to improving 
health outcomes in Central Appalachia. Smoking prevalence is higher in Central Appalachia 
compared to the rest of the country(3, 10).  Similarly, researchers have concluded that the cancer 
screening use within recommended guidelines is significantly lower within Appalachia (11-18).  
D. A Focus on Preventative Screening Use 
 This thesis focuses on a specific health behavior, preventative screening use for the 
following: blood pressure, blood cholesterol, colorectal cancer, prostate cancer, breast cancer and 
lung cancer screenings. These screenings were examined due to their direct connection to 
existing mortality disparities in the region. Preventative health screenings do not necessarily 
impact disease prevalence, but can lower disease mortality through early detection and more 
effective treatment (29). In the case of cancer mortality, low screening use contributes to late-
stage diagnoses which can in turn lead to poorer treatment outcomes. While there is a general 
perception of low cancer screening use, the lack of research regarding late-stage diagnosis rates 
helps to highlight the need for further research in the area (9). Cancer screening use deserves 
special attention in Central Appalachia given the mortality disparities for all cancers combined, 
lung and colorectal cancer. Similarly, blood pressure and blood cholesterol screenings are 
directly associated with the existing mortality disparity for heart disease. Patients with high 
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cholesterol levels are at a higher risk of developing heart disease, and the prevalence of high 
cholesterol in the region is higher than the national average (30). Hypertension or high blood 
pressure is a major risk for heart disease and stroke as well as other serious medical 
conditions(31). Prior research not only indicates high prevalence of hypertension in the region, 
but also reveals high hospitalization rates for hypertension(29). Increased screening for 
hypertension could improve the mortality disparities for heart disease and stroke by getting at 
risk patients identified and treated. Given the significance for existing health disparities, I 
examine preventative screening use for an underserved patient population in the region.   
To help contextualize the factors affecting preventative screening use, I utilize 
Andersen’s Behavioral Model of Health Services Use, which has guided research on health 
behaviors and outcomes within the US for the last half-century. In Andersen’s model, 
predisposing, enabling and need factors at environmental and individual levels influence health 
behaviors and health outcomes (32, 33). Figure 4 displays Andersen’s model(33). 
 
Figure 4. Andersen’s Behavioral Model of Health Services Use, Source: Andersen, 2008 
Predisposing characteristics such as age, gender and education affect both the likelihood a patient 
will need health care and their ability to access health care when needed. Enabling characteristics 
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such as income and health insurance coverage influence a patient’s ability to receive health care. 
Likewise, a patient’s self-assessed and clinically assessed health needs impact health behaviors 
and outcomes.  
At the national level, previous research fits within this application of Andersen’s model. 
Healthcare access, an enabling characteristic measured in part by having a routine or regular 
physician, has correlated in multiple separate studies to rates of breast, cervical, colorectal, 
prostate, and general preventative screenings (34-38). Additionally, predisposing individual 
characteristics of education and recognizing the need for screenings have both correlated to use 
of prostate and colorectal screenings respectively (37, 38).  Similar research has occurred at the 
regional level.  
 Within Appalachia, previous research on preventative health can be understood through 
Andersen’s model. The importance of cost, an enabling factor, has been linked to lower use of 
cancer screenings and other preventative screenings (39, 40). Predisposing characteristics 
including gender, cultural beliefs, awareness of need for screening have all been connected to 
generalized low use of cancer, cholesterol and preventative screenings (41-43). Other individual 
characteristics include living in remote locations, lack of transportation and low access to 
medical care (14, 17, 40, 44). For example, both a woman’s physical distance from a health care 
provider and lack of insurance can impede her access to cancer screenings (3). Researchers have 
found that late stage diagnosis of breast cancer is more prevalent for patients who live more than 
15 miles away from a health center or lack health insurance (45).  
I contribute to existing research by being the first to study the unique clinical setting of 
the Remote Area Medical Clinic in Wise County, Virginia. Doing so allows for an 
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unprecedented focus on preventative screening use for critically underserved patients in the 
region.  
F. Remote Area Medical Volunteer Corps  
The Remote Area Medical Volunteer Corps (RAM) was founded in 1985 to bring 
medical care to remote regions around the world. RAM operates multiday clinics to provide 
medical, dental and vision care for the uninsured and underinsured. Though RAM’s work 
originated in South America, they have more recently shifted to delivering care to underserved 
communities in the US.  RAM has provided an estimated 90 million dollars in free health care 
treatment to over 180,000 patients across 180 clinics nationwide (2). The majority of RAM’s 
current efforts are directed towards rural America, including Appalachia. Within Appalachia 
alone, RAM is scheduled to operate 12 clinics in the 2015 calendar year. 
RAM began hosting clinics in Wise County, Virginia in 2000 at the Wise County 
Fairgrounds. This event is the largest medical outreach clinic in the US (2). In 2014, 2,244 
patients received free care during the three-day clinic from July 18-20. There were a total of 
5,227 medical (59.4%), dental (24.7%) and vision care (15.9%) encounters during this period 
(1). The total estimated value of these encounters was $1,930,572 (1). RAM serves as a critical 
source of care for the underserved patient population in the region. Before coming to the RAM 
clinic, patients were asked the years since they had last been to the doctor or seen another health 
care provider. Table 1Table 1summarizes patient’s self-reported years since previous encounter 
with a health care professional.   
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Table 1. Years since contact with health care provider 
Years Medical Care 
(% of patients) 
Dental Care 
(% of patients) 
Vision Care 
(% of patients) 
0 to 1 72.8 34.0 31.2 
1 to 2  6.6 14.0 16.3 
2 to 3 3.4 9.5 8.8 
3 to 4 1.3 4.8 5.0 
4 to 5 2.5 6.3 5.3 
5 to 10 2.8 11.1 9.6 
More than 10 2.9 12.5 12.6 
Don’t remember 
or no answer 
7.9 7.8 11.2 
Source: RAM Clinic in Wise, Clinic Report for 2014 
 
Over 1 in 4 patients at the RAM’s Wise Clinic had not seen a health care professional within the 
past year for medical care (1). Access to dental and vision care was considerably lower, with 
around two-thirds of patients reporting no encounters with a dental or vision provider in the past 
year (1). Due to the widespread need in the surrounding area, the RAM clinic in Wise has a 
regional scope.  
  Patients at the Wise clinic arrive and wait outside the fairgrounds to receive numbers. 
Traveling largely from the surrounding counties of Tennessee, Virginia, West Virginia and 
Kentucky, these patients camp out at the fairgrounds until they receive the needed care. Figure 5 
visualizes the regional scope of the Wise County RAM Clinic by shading surrounding zip codes 
according to patient count data.  
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Figure 5. RAM Patients by Zip Code 
The sheer number of RAM clinics within Appalachia, as well as the high number of patients 
attending these clinics, indicates the high number of underserved patients in the region, and 
demonstrates the need to improve health care policy for the region. RAM not only helps improve 
access to health care for patients in the regions, but also provides a critical research opportunity.  
The size of the RAM clinic in Wise provides an opportunity to reach a large sample of 
underserved patients within the region. In turn, this sample provides an understanding of health 
behavior for not only RAM patients, but also for the surrounding region (9).  
  
"
!
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V. Methodology 
 Over the course of three days, 205 patients at the RAM Clinic in Wise County, VA were 
surveyed in order to understand preventative screening use and patient characteristics affecting 
screening use. Survey questions were taken from two national health surveys:  the Behavioral 
Risk Factor Surveillance System (BRFSS) and the National Health interview Survey (NHIS). 
Patient characteristics and screening rates were compared to US Census data and previous 
analysis of the two national health surveys. In addition, multi-variable regression models were 
selected according to Akaike Information Criterion (AIC) in order to identify the best predictors 
of screening use.   
A. Participants and Sampling 
 Patients attending the RAM clinic in Wise, Virginia were surveyed July 17-19 2014. 
Male and female patients age 18 and older were eligible to participate in the survey. Non-random 
sampling was conducted. All patients meeting age requirements were asked to participate while 
waiting to receive care.  Patients were approached as groups and individuals. In total, 205 
surveys were completed; fewer than 20 patients approached refused to participate.  
B. Measures 
Questions for the survey were primarily taken from the Behavioral Risk Factor 
Surveillance System (BRFSS) and the National Health interview Survey (NHIS). These surveys 
situate RAM patients within a national context because prior research has established summary 
health statistics on individual characteristics and preventative screening use (46). Appendix 3 
documents the source of each question. Of the 29 survey questions, only six questions were 
written for the purpose of this project and previously un-validated. The previously un-validated 
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questions were for the following variables: reason for health care visits in past year, number of 
health care visits at a free health clinic in the past year, whether preventative screenings had ever 
been received at a RAM clinic and self-described barriers to preventative screening use. Patient 
responses were limited to preselected options for all questions except for age and the number of 
health care visits in the past year. National measures were taken from previous analysis of these 
national surveys and US Census data.   
C. Key Variables 
Dependent Variables 
 Use of the following preventative screenings was assessed: blood pressure, blood 
cholesterol, colorectal cancer, prostate cancer, breast cancer and lung cancer screenings. For 
blood pressure and blood cholesterol screenings, patients were asked whether or not they had 
received the screening in the past year. For all others, patients were asked if they had ever 
received the screening and the time since their last screening.  Binary indicators were created for 
each screening according to United States Preventative Screening Task Force (USPTF) 
guidelines (47). Though the prostate cancer screening, prostate-specific antigen test, is no longer 
recommended by USPTF, an indicator was created from previous guidelines in order to compare 
rates to previous national studies.  Table 2 summarizes the classification for each missed 
screening indicator.  
 
 
 
 
23 
 
Table 2. Current USPTF Guidelines for Preventative Screenings 
 Blood 
Pressure 
Blood 
Cholesterol  
Breast 
Cancer 
Cervical 
Cancer 
Prostate Cancer Colon 
Cancer 
Lung 
Cancer 
USPTF  
Guideline: 
Gender, 
Age & 
Timeframe 
All, 18+, 
Previous 
year 
Male, 35+, 
Previous 
year; 
Female, 
45+, 
Previous 
year 
Female, 
40-75, 
Previous 2 
years 
Female, 
21-65, 
Previous 3 
years 
Not 
Recommended; 
Previous 
recommendation: 
Male, 40+, 
Previous two 
years 
All, 50+, 
Previous 2 
years 
Smoker or 
previous 
smoker 
within past 
15 years, 
55-80, 
Previous 
Year 
 
From the individual missed screening indicators, two additional variables were created. A 
binary indicator was created to determine if a patient was out of line with at least one USPTF 
recommendation. A second indicator was created to determine the proportion of screenings a 
patient was missing according to guidelines. In both indicators, the missed prostate screening 
indicator was excluded because it is no longer recommended by USPTF.  
Independent Variables 
Patient demographics were measured by questions that asked patient’s their age, race, 
education and zip code. Gender was inferred from responses to the questionnaire or direct 
observation. Questions on income and insurance coverage were not permitted by RAM. To 
estimate these variables, patients’ home zip codes were used to retrieve county level data from 
the American Community Survey (ACS).  
To gauge patient’s access to health care, the following variables were included: 
frequency of health care visits in the past year, access to a personal provider, doctor’s office as a 
usual source of care, emergency room as a usual source of care, impact of cost on the decision to 
seek medical care, impact of cost on adherence to prescription medication, and a routine physical 
checkup in the past year. All variables were dichotomized for analysis. Health care visits were 
categorized into none or at least one health care visit in the past year. For the purposes of this 
24 
 
analysis, not visiting a health care provider in the past year was considered an indicator of low 
access to health care. To determine patient’s self-assessed need for healthcare, they were asked 
to rate their own health according to the following: “excellent”, “very good”, “good”, “fair” or 
“poor.”  
If patients were out of guidelines with at least one screening, they were asked, “Did you 
not receive one of the above screenings or routine check-up for any of the following reasons? 
Cost, unaware the screening was needed, did not think the screening was worth the cost, unsure 
of where to receive the screening, travel distance to receive the screening or none apply.” In 
addition, patients were asked if they had previously received any of the preventative screenings 
at a RAM clinic. 
D. Procedures 
Surveys began the Thursday, July 17 before the clinic’s opening. Patients were approached in 
the fairground’s parking area as they waited for the clinic to open the following morning. During 
the clinic Friday and Saturday, surveys took place in two main waiting areas, the parking area 
outside of the clinic and the stadium seating within the fairgrounds.  Patients surveyed in the 
parking area were waiting to receive tickets to enter the fairgrounds; patients in the fairgrounds 
stadium seating had been allowed to enter the fairgrounds, but were still waiting to complete 
patient registration. Patients surveyed in the stadium seating also included patients seeking cover 
from inclement weather. On Friday and Saturday, surveys were conducted from the clinic’s 
opening (5:00 AM) until early evening.  
Two interviewers approached patients and asked for their participation in the study. In all 
cases, surveys were completed according to the form provided in Appendix 2. Patients were able 
to read the form as the questions were asked and their subsequent responses were recorded. 
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E. Analysis  
 The analysis was split into the three parts:  patient characteristics, preventative screening 
use and factors affecting screening use. All statistical analysis was conducted in R version 3.1.1.  
i. Patient Characteristic Comparison   
 Patient characteristics were compared to the national population when relevant national 
data was available. A test of a single proportion was used to determine if responses for gender, 
race, education, health insurance coverage and self-rated health were statistically different from 
the national population. National data for gender, race, education and health insurance coverage 
were from corresponding US Census sources (48-51). For the self-rated health comparison and 
use of a routine checkup within the past year, national data was extracted from pervious analysis 
of BRFSS national results (52). No direct comparisons were available for the following study 
variables: access to a routine provider, frequency of visits in the past year, cost as a barrier for 
seeking medical care and prescription medication use and source of health care.  A test of a 
single mean was conducted for household income using national data from the US Census (53).  
ii. Preventative Screening Comparisons  
Preventing screening rates for RAM patients were compared to national data for the 
following screenings: breast cancer, cervical cancer, colorectal cancer and prostate cancer. To 
determine statistical significance for difference in screening rates, a test of a single proportion 
was conducted for each screening using data from prior analysis of BRFSS at the national level 
(52, 54). For cervical cancer rates nationally, women 18 to 65 were included while in the study, 
only women 21 to 65 were asked per USPTF recommendations. Comparisons to the national 
population were not possible for blood pressure, blood cholesterol and lung cancer screening 
rates.  
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iii. Factors Affecting Screening Use 
 To understand why patients were missing screenings, I completed regressions of patient 
characteristics to screening indicators, and asked patients who were missing screenings the why 
they had missed the screening. Multi-variable regression model selection was conducted to 
understand which patient characteristics best correlated to each individual screening and the 
proportion of missed screenings. Prostate cancer screening was excluded from the model 
selection because it is no longer recommended. The Akaike Information Criterion (AIC) was 
used to incorporate a trade-off between goodness of fit and complexity of the model. In AIC 
model selection, models are penalized according for the number of predictors included. The 
model selection was started with all patient characteristics included with a few notable 
exceptions. Gender was excluded for the gender specific screenings, and the indicator for a 
health care visit in the past year was excluded from the blood pressure and blood cholesterol 
indicators. In addition, I calculated the percent of patients listing each self-described barrier to 
receiving a preventative screening.  
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VI. Results 
A. RAM Patient Characteristics  
 
Responses for demographic variables illustrate the low socioeconomic status for RAM 
patients. Education and income measures fall below the average national population. Over a 
quarter of patients, 27.2 percent did not graduate high school compared to just 12 percent of the 
national population (49). Similarly, the percent of patients, who received some education beyond 
high school, 19.3 percent, falls below the national average of 57.9 percent (49). The average 
income for the counties of RAM patients is lower than the national average. Compared to the 
national average of $53, 046, the average income for RAM patient counties is $36, 170 (SE=472) 
(53). Household incomes for RAM patients likely fall below county averages, but the county 
level estimates provide a conservative estimate that is indicative of the poor socioeconomic 
status of the surrounding region. Demographic variables for RAM patients are summarized in 
Table 3. All differences from the national average were statistically significant at a 99% 
confidence level. Within Andersen’s model, these low socioeconomic indicators predispose 
patients to poorer health outcomes, worse health behaviors and lower access to health care.  
Table 3: Comparison of Patient Demographics to the National Population 
  n Value National Value 
Female (%) 202 61.39 50.80** 
White (%) 205 0.94 77.70** 
Education (%) 202   
Not a high school graduate 
 
27.23 12.56** 
High school graduate  
 
53.47 29.54** 
Post high school education 
 
19.31 58.00** 
Median Household Income (SE) 205 36, 170 
(472) 
53000 ** 
Note. A test of a single mean for household income and tests of single proportions for gender, race and education 
were completed using published US Census data. Significance indicators correspond as follows: . p<0.1; *p<0.05; 
**p<0.01 
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RAM patients have low access to health care as measured by study variables: health care 
visits within the past year, cost as a barrier, having a personal provider, usual source of care and 
a recent routine physical checkup.  Over 15 percent of patients had not seen a health care 
professional in the past year. Cost is a barrier to seeking health care for over two-thirds of 
patients, 68.14 percent, significantly higher than 10 percent at the national level (55).  For 
adherence to prescription medication in the past 12 months, cost is a barrier for fewer patients, 
44.6 percent; however, this is still a large portion of the overall patient population. Forty-one 
percent of patients did not have someone they considered their personal provider. Over a third 
listed the emergency room as a usual source of health care. Compared to the national value of 
66.7 percent, under a half of RAM patients had received a routine physical checkup within the 
past 12 months.  Table 4 summarizes the results for health care access.  
Table 4: Health Care Access for RAM Patients 
  n % National Value 
Personal Provider  
None 
204 41.18  
 Only One   47.55  
 More than one   11.27  
Health care visits in past year  
0 
204  
15.20 
 
 1 to 4  44.61  
 5 to 11  18.14  
 12  11.27  
 12+  10.78  
Cost as a Barrier Health Care Visit 204 68.14 10.70** 
 Prescription Medication Use 202 44.55  
Source of Care  
Emergency Room 
204 37.07  
 Doctor's Office  52.20  
 Hospital Outpatient Department  4.39  
 Urgent Care Center  6.34  
 Health Center  9.27  
 Other  8.29  
 No usual place  10.24  
Routine Physical checkup  204 49.51 66.70** 
Note. Table 4 summarizes health care access variables for RAM patients. Tests of a single proportion were 
completed using published analysis of BRFSS when available. Significance indicators correspond as follows: . 
p<0.1; *p<0.05; **p<0.01 
 
29 
 
 Patient characteristics in Andersen’s third category, need, indicate low health status for 
RAM patients. Less than half of patients rated their health as good or better compared to the 
national average of 66.7 percent. Table 5 summarizes patients’ self-rated health status.  
Table 5. Patient Health Status 
 n % National 
Value 
Health Status  203   
Poor  15.76  
Fair  36.95  
Good  34.98  
Very Good  10.34  
Excellent  1.97  
    
Good or better  47.29 85.00** 
Note. Table 5 summarizes patients’ self-rated health status. Test of a single proportion was completed using 
published analysis of BRFSS when available. Significance indicators correspond as follows: . p<0.1; *p<0.05; 
**p<0.01 
 
Taken together these characteristics demonstrate that RAM patients have poor socioeconomic 
status, low access to health care and poor health.   
B. Preventative Screening Rates 
RAM patients have low adherence to USPTF guidelines for all preventative screenings 
and rates fall below national averages for breast, cervical and colorectal cancer screenings. Close 
to 1 in 5 patients (16.2%) had not had their blood pressure checked within the past year by a 
health care professional. One-third of males age 35 and older and females age 45 and older were 
missing a blood cholesterol screening for the previous year. Compared to the national rate of 
64.2 percent, only 43.18 percent of patients age 50 and older were within recommended 
guidelines for a colorectal cancer screening. Just over a half, 55.6 percent of women age 40-75 
had a mammogram within the previous two years compared to 75.2 percent of the national 
population. Under a half (49.57%) of women age 21-65 had a Pap-test within the previous year; 
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a rate that’s drastically lower than the national average of 81 percent. Few (13.64%) smokers or 
previous smokers age 55-80 had a lung cancer screening within the past year. A half of men age 
40 and older had a prostate cancer screening within the past two years. With the exception of the 
prostate cancer screening, these rates indicate the low overall proportion of patients in 
accordance with USPTF screening recommendations. The national comparisons for these 
USPTF recommended screenings show lower adherence for screenings that is significant at a 99 
percent confidence level. Table 6 summarizes the screening rates and USPTF guidelines for each 
screening. When these missed screenings are aggregated into a combined indicator, over a half of 
patients (60.98%) were missing at least one recommended screening. Overall, RAM patients on 
average were out of line with a third (34.45 %) of the relevant USPTF screening guidelines.   
Table 6: Preventative Screening Rates 
   Patients n % National % 
Blood Pressure  All, 18+, Previous year 204 83.82  
Blood Cholesterol  Male, 35+, Previous year; Female, 45+, 
Previous year 
104 67.31  
Colon Cancer  All, 50+, Previous two years 63 43.18 64.2** 
Breast Cancer  Female, 40-75, Previous two years 72 55.56 75.2** 
Cervical Cancer  Female,21-65, Previous three years 105 49.57 81** 
Lung Cancer  All smokers or previous smokers within past 
15 years, 55-80, Previous year 
22 13.64  
Prostate Cancer  Men, 40+, Previous two years 40 50.00 54.8 
At Least One Missed   Missing at least one recommended 
screening 
204 60.98  
Average Percent of Missed 
Screenings  
Percent of recommended screenings missed 204 34.45  
Note. Table 6 summarizes the percent of patients in accordance with the USPTF recommendations for each 
screening, as well as the average percent of missed screenings and the percent of patients missing at least one 
screening. Tests of a single proportion were completed using published analysis of BRFSS when available to 
compare screening rates to the national value. Significance indicators correspond as follows: . p<0.1; *p<0.05; 
**p<0.01 
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C. Factors limiting preventative screening rates 
i. Multi-variable models for screening use 
 AIC model selection identifies the best multi-variable model for screening use starting 
with all patient variables. The model selection results are organized by screening.  
Blood Pressure 
In the initial model for blood pressure screening, cost as a prohibitive factor for 
adherence to prescription medication, being female and a missed routine checkup are significant 
coefficients. Both cost of prescription medication as a barrier and being female decrease the odds 
ratio of a missed screening. Missing a routine checkup within the past year increases the odds 
ratio of not receiving a blood pressure screening.  
In the final model, the number of variables included narrows from eight to four with the 
following: gender, cost as a barrier to medication use, access to a personal provider and a missed 
routine checkup. Being female, having access to a personal provider and not listing cost as a 
barrier to medication use all increase the odds a patient had received a blood pressure screening.  
Each indicator decreases the odds ratio of not receiving a blood pressure screening. These 
coefficients are all similar in magnitude, and drastically decrease the odds a patient was missing 
a screening. For example, the odds of missing a blood pressure check for a patient with a 
personal provider are one fifth the odds of a patient who does not have access to a provider. No 
routine check-up considerably increases the odds ratio of a missed blood pressure screening. The 
odds of a patient with a missing a blood pressure screening is 27 times higher if they also had a 
missed routine checkup then if they did not. Table 7 displays the regression results from the 
initial and final models.  
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Table 7. AIC Model Selection Results—Blood Pressure 
 Initial 
(1) 
Final 
(2) 
Age 1.00 
(1.03) 
 
Female 0.25** 
(1.94) 
0.25** 
(1.64) 
Education: High School Graduate 1.09 
(2.13) 
 
Post High School 1.42 
(2.53) 
 
Visit in Past Year 0.03 
(2.26) 
 
Personal Provider 1.20 
(2.68) 
0.21* 
(1.89) 
Cost as a barrier: Healthcare Visit  0.83 
(2.38) 
 
Medication Use 0.31** 
(2.12) 
0.21** 
(1.72) 
Emergency Room as usual source 1.10 
(1.97) 
 
Doctor's office as usual source 0.41 
(2.58) 
 
Missed Routine Checkup 14.87** 
(3.56) 
26.74** 
(3.01) 
Poor Health 2.82 
(2.25) 
 
Constant 0.63 
(7.43) 
0.10* 
(3.04) 
Observations 199 203 
Log Likelihood -37.75 -53.37 
Akaike Inf. Crit. 105.51 120.74 
Note. Table 7 summarizes the AIC model selection results. The odds-ratio estimates included in both the initial and 
final mode are shown. Significance indicators correspond as follows: . p<0.1; *p<0.05; **p<0.01 
Blood Cholesterol 
 For a missed blood cholesterol screening, cost as a barrier and access to a personal 
provider are the only two significant coefficients with all variables are included. Access to a 
personal provider decreases the odds ratio of a missed screening while listing cost as a 
prohibitive factor for seeking care increases the odds ratio of a missed screening. AIC model 
selection narrows the number of predictors down to just cost and access to a personal provider. 
Patients who listed cost as a prohibitive factor are over three times as likely to have a missed 
screening then patients who did not. Patients with access to at least one personal provider are 
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close a fifth as likely as a patient without a personal provider to miss their screening. In both 
cases, the statistical significance of the coefficients increases from the initial to final model. 
Table 8 displays the regression results from the initial and final models.  
Table 8. Model Selection Results—Blood Cholesterol 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note. This table summarizes the AIC model selection results. The odds-ratio estimates included in both the initial 
and final mode are shown. Significance indicators correspond as follows: . p<0.1; *p<0.05; **p<0.01 
Colorectal Cancer  
In the initial model for a missed colorectal cancer screening, there are no significant 
predictors for a missed screening. The AIC model selection decreases the number of predictors 
to three variables: age, a health care visit in the past year and access to a personal provider. 
However, none of these coefficients are statistically significant. Table 9 summarizes these 
results. 
 Initial 
(1) 
Final 
(2) 
Age 0.99 
(1.03) 
 
Female 1.65** 
(1.80) 
 
Education: High School Graduate 0.53 
(1.82) 
 
Post High School 0.60 
(2.23) 
 
Personal Provider 0.18* 
(2.68) 
0.21** 
(2.00) 
Cost as a barrier: Healthcare Visit  3.81. 
(2.01) 
3.60* 
(1.77) 
Medication Use 1.15 
(1.81) 
 
Emergency Room as usual source 1.09 
(1.96) 
 
Doctor's office as usual source 0.81 
(1.96) 
 
Missed Routine Checkup 1.26 
(1.80) 
 
Poor Health 1.13 
(1.77) 
 
Constant 1.6E12 
(Inf.00) 
1.5E6 
(Inf. 00) 
Observations 100 104 
Log Likelihood -45.93 -49.96 
Akaike Inf. Crit. 119.87 107.92 
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Table 9. Model Selection Results—Colorectal Cancer Screening 
 Initial 
(1) 
Final 
(2) 
Age 1.06 
(1.07) 
1.09 
(1.06) 
Female 1.08 
(1.07) 
 
Education: High School Graduate 1.43 
(2.01) 
 
Post High School 3.93 
(3.93) 
 
Visit in Past Year 0 
(Inf.00) 
0 
(Inf.00) 
Personal Provider 2264262302 
(Inf.00) 
1.6E8 
(Inf.00) 
Cost as a barrier: Healthcare Visit  1.1 
(2.32) 
 
Medication Use 0.68 
(2.27) 
 
Emergency Room as usual source 3.78 
(3.54) 
 
Doctor's office as usual source 2.97 
(2.17) 
 
Missed Routine Checkup 1.99 
(2.49) 
 
Poor Health 2.19 
(2.27) 
 
Constant 158575.2 
(Inf.00) 
98625.24 
(Inf.00) 
Observations 60 63 
Log Likelihood -29.38 -35.4 
Akaike Inf. Crit. 84.76 78.8 
Note. Table 9 summarizes the AIC model selection results. Coefficient estimates included in both the initial and 
final mode are shown. Significance indicators correspond as follows: . p<0.1; *p<0.05; **p<0.01 
Breast Cancer 
For a mammogram, only a missed routine checkup affects the odds ratio of a missed 
screening with statistical significance. This relationship holds in both the initial and final models. 
In the model selection, the number of predictors narrows to just two variables: age and a missed 
routine checkup. In the final model, the statistical significance of a missed routine checkup as a 
predictor increases from a 90 percent confidence level to a 95 percent confidence level, while the 
magnitude of the coefficient decreases slightly. In the final model, a woman with a missed 
routine checkup is close to three times more likely to miss a mammogram screening than a 
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woman who had a routine checkup within the past year. Table 10 summarizes the model 
selection results for breast cancer screening.  
Table 10. Model Selection Results—Mammogram 
 Initial 
(1) 
Final 
(2) 
Age 0.95 
(1.03) 
0.96 
(1.03) 
Education: High School Graduate 2.04 
(1.84) 
 
Post High School 2.62 
(2.24) 
 
Visit in Past Year 0 
(Inf.00) 
 
Personal Provider 1.84 
(2.58) 
 
Cost as a barrier: Healthcare Visit  0.89 
(1.97) 
 
Medication Use 1.03 
(1.95) 
 
Emergency Room as usual source 0.73 
(2.05) 
 
Doctor's office as usual source 1.09 
(2.08) 
 
Missed Routine Checkup 3.11. 
(1.92) 
2.90* 
(1.66) 
Poor Health 2.14 
(1.87) 
 
Constant 11822762 
(Inf.00) 
4.06 
-4.58 
Observations 70 72 
Log Likelihood -41.62 -46 
Akaike Inf. Crit. 109.25 98.01 
Note. Table 10 summarizes the AIC model selection results. The odds-ratio estimates included in both the initial and 
final mode are shown. Significance indicators correspond as follows: . p<0.1; *p<0.05; **p<0.01 
Cervical Cancer  
In the initial model for cervical cancer screening, there are no significant predictors of 
screening use. The final model includes age, access to a personal provider and a visit to a health 
professional in the past year.  Older age subtlety increases the odds ratio of a missed screening. 
Older women are 1.07 times as likely to miss their screening as younger women. Both access to 
a personal provider and health care visits in the past year decrease the odds ratio of a missed pap 
test with statistical significance. A woman who had visited a health care professional in the past 
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year is three-tenths as likely to miss their screening as a woman who had seen a health care 
professional. Similarly, a woman with access to more than one personal provider is one-fifth as 
likely to miss the pap screening as a woman who does not have access to a personal provider. 
Table 11 displays the results for cervical cancer screening.  
Table 11. Model Selection Results—Pap Test 
 Initial 
(1) 
Final 
(2) 
Age 1.06 
(1.02) 
1.07** 
(1.02) 
Education: High School Graduate 0.53 
(1.77) 
 
Post High School 1.03 
(1.9) 
 
Visit in Past Year 0.25 
(2.43) 
0.28* 
(2.09) 
Personal Provider 0.41 
(1.99) 
0.32 . 
(1.73) 
Cost as a barrier: Healthcare Visit  2.52 
(1.79) 
 
Medication Use 0.82 
(1.76) 
 
Emergency Room as usual source 1.05 
(1.73) 
 
Doctor's office as usual source 0.9 
(1.8) 
 
Missed Routine Checkup 0.75 
(1.72) 
 
Poor Health 1.62 
(1.68) 
 
Constant 0.27 
(3.47) 
0.3 
(2.44) 
Observations 103 105 
Log Likelihood -60.47 -64.63 
Akaike Inf. Crit. 146.94 137.27 
Note. Table 11 summarizes the AIC model selection results. The odds-ratio estimates included in both the initial and 
final mode are shown. Significance indicators correspond as follows: . p<0.1; *p<0.05; **p<0.01 
Lung Cancer  
 Given the very low number of patients who had received a lung cancer screening, a 
multi-variable regression model is not appropriate to analyze use of this screening. Only 3 of 22 
relevant patients had received the screening. As a result, all patient responses predict a missed 
screening and the multi-variable regression models do not converge.  
37 
 
Proportion of Missed Screenings  
In the initial model, age, receiving a routine checkup and a health care visit in the past 
year all correlate to the proportion of missed screenings for a patient. Age and a missed routine 
checkup positively correlate while a visit in the past year negatively correlates. Age and a health 
care visit in the past year are significant at a 99.9 percent confidence level. In the final model, the 
AIC model selection narrows the number of predictors to just age, a visit in the past year, the 
poor health indicator and a missed routine checkup. Patients who visited a health care 
professional in the past year are missing fewer of the preventative screenings that apply to them 
specifically. Both age and a missed routine checkup positively correlate to the proportion of 
missed screenings. Older patients and those who did have a routine checkup in the past year are 
more likely to miss a higher proportion of their preventative screenings. Table 12 summarizes 
the regression results from the initial and final models.  
Table 12. Model Selection Results- Proportion of Missed Screenings 
 Initial 
(1) 
Final 
(2) 
Age 0.01** 
(0.002) 
0.01** 
(0.002) 
Female 0.02 
(0.04) 
 
Education: High School Graduate 0.01 
(0.05) 
 
Post High School 0.05 
(0.06) 
 
Visit in Past Year -0.56** 
(0.07) 
-0.57** 
(0.06) 
Personal Provider -0.0002 
(0.06) 
 
Cost as a barrier: Healthcare Visit 0.04 
(0.05) 
 
Medication Use 0.004 
(0.05) 
 
Emergency Room as usual source -0.05 
(0.05) 
 
Doctor's office as usual source -0.05 
(0.05) 
 
Missed Routine Checkup 0.09. 
(0.05) 
0.12* 
(0.04) 
Poor Health 0.07 0.06 
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(0.05) (0.04) 
Constant 0.41** 
(0.12) 
0.42** 
(0.09) 
Observations 199 203 
R2 0.40 0.35 
Adjusted R2 0.35 0.34 
Residual Std. Error 0.29 (df = 184) 0.29 (df = 198) 
F Statistic 8.61*** (df = 14; 184) 27.14*** (df = 4; 198) 
Note. Table 1Table 12 summarizes the AIC model selection results. The coefficient estimates included in both the 
initial and final models are shown. Significance indicators correspond as follows: . p<0.1; *p<0.05; **p<0.01 
Aggregated Results of AIC Model Selection 
Taken together, the aggregated results indicate the importance of a healthcare visit within 
the past year, age, access to a personal provider and a missed routine checkup as each variable is 
significant in at least two of the final models. A visit to a healthcare profession within the past 
year negatively correlates to the proportion of missed screenings and decreases the odds ratio of 
a missing a cervical cancer screening. Age positively correlates to the proportion of missed 
screenings and increases the odds ratio for missing the cervical cancer screening. Access to a 
personal provider corresponds to decreased odds ratios of a missed blood pressure, blood 
cholesterol and cervical cancer screening. Not having a routine checkup in the past year 
positively correlates to the proportion of missed screenings corresponds to increased odds ratios 
for missed blood pressure and breast cancer screenings. Notably absent in the in all screening 
models are the effect of education level and self-rated health. Similarly, cost as a barrier to health 
is a predictor in only one of the final models. Figure 1Figure 6 summarizes the direction and 
significance for each patient variable for all the screenings. 
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Figure 6. Summary of Regression Models 
 
Further context of screening use  
Cost was the most commonly cited reason a patient did not receive a screening. Ninety-
four patients (46.53%) listed cost as a barrier. Close to 1 in 8 patients stated that travel was a 
factor leading them to not receive a clinical screening.  Patients were also both unaware the 
screening was needed and unsure of where to receive the screening. Just under ten percent of 
patients were unaware the screening was needed, and 6.93 percent of patients were unsure of 
where to receive the screening. Table 13 summarizes the self-described barriers to preventative 
services. In addition, patients were asked if they had ever received a preventative screening at 
any RAM clinic. Only 1 in 5 patients had ever done so.  
Blood Pressure
Blood 
Cholesterol
Colorectal 
Cancer
Breast Cancer Cervical Cancer
Porpotion of 
Missed 
Screenings
Age ** **
Female **
Education
Visit in past year * **
Personal Provider * * .
Cost as a barrier:  
Healthcare Visit 
*
Cost as a barrier: 
Medication Use
**
Emergency room as 
usual source
Doctor's ofice as usual 
source 
Missed routine checkup ** * *
Poor Health
Increased probability of missed screening
Decreased probability of missed screening
Included in final model but non signifcant coefficient
Not included in final model 
Not included in initial model
Significance indicators correspond as follows: . p<0.1; *p<0.05; **p<0.01
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Table 13. Reasons for Missed Screening 
Reason for missed 
screening 
n %  
Cost 94 46.53 
Unaware screening was 
needed  
20 9.90 
Unsure of where to receive 
screening 
14 6.93 
Travel  26 12.87 
No Reason  8 3.96 
None apply 33 16.34 
D. Sample Bias Concerns 
To help address concerns for selection bias within the Wise Clinic, patient data were 
compared between sample and clinic data when possible. This comparison was conducted for 
patient age, zip code, race and visits to a health care professional within the past year. No 
statistically significant difference exists between the mean age for the sample size and the overall 
clinic population aged 18 and older. Similarly, zip code data for sample and clinic populations do 
not reveal any key distinctions. A side-by-side comparison found in Appendix 1 shows that more 
zip codes are represented in the clinic data; however, this would be expected given the larger 
count of observations and high number of zip codes being represented by just a few patients. 
Importantly both show that the same counties immediately surrounding the clinic have the 
largest patient representation.  
A chi-squared goodness of fit test for all race classifications potentially sampled (White, 
Black, Hispanic, Asian, Native American and Other) reveals a discrepancy between the sampled 
population and the clinic-wide population. However, this result is not unexpected, given the low 
counts of Hispanic, Asian and Native American respondents at the clinic. For example, under 
sampling of the 15 Hispanic patients out of 2,244 could be expected given the low probability of 
encountering these patients. When the same test is repeated for a classification of white and all 
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other races, there is no difference between the sample and clinic population. Similarly, a chi-
squared goodness of fit test indicates that the sampled patient population does not have lower 
access to care than the overall clinic population as measured by the number of patients who 
reported seeing a health care professional in the past year. In fact, the test shows that a bias exists 
in the opposite direction, sampled patients have better access. Overall a comparison between the 
sample and overall patient population for age, zip code, race and access to a health care 
professional within the past year helps remove concerns for sample bias.   
E. Limitations and Implications for Further Research 
 Several limitations on the data and collection procedures are worth highlighting. First, 
these results are based off of patient-reported data, which could be inaccurate. For example, 
patients may have trouble recalling the last time they received a preventative screening, which 
would subsequently affect whether or not they were missing the screening according to USPTF 
guidelines. Access to electronic medical records for patients in the region could prove to be a 
more reliable data source in future research. However given that a majority of the survey 
questions have been previously validated at the national level, the reliance on patient reported 
data should not be considered a severe limitation. Second, non-random sampling was conducted. 
While selection bias could skew the data presented in this thesis, the comparison between sample 
and clinic-wide data suggests that no such bias exists.  Incorporating these questions with the 
data the clinic collects on all patients would eliminate this cause for concern. Lastly, information 
on patients’ health insurance coverage and income was not collected. While these two variables 
are important factors affecting access to health care, the organizers of the RAM clinic prohibited 
these survey questions. Future inclusion of this data would provide a more complete 
understanding of the patients attending RAM.  
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VII. Discussion 
 Over the course of three days, 205 surveys were conducted at the RAM Clinic in Wise 
County, Virginia in order to understand preventative screening rates and factors affecting use for 
medically underserved patients in Central Appalachia. Screening rates according to USPTF 
guidelines were calculated from patient responses, and these rates were compared to national 
values. Patient demographic and health care access variables were used to understand why 
patients were missing screenings. The implications of low screening rates, role for health care 
reform to improve screening rates and recommendations for the RAM Clinic are discussed in the 
subsequent sections. While general policy connections are made in Section A, the specific 
connection of these findings to health policy, specifically health care reform, are detailed in 
section B.  
A. Implications of Low Screening Rates 
Low preventative screening use for RAM patients highlights the need for policy 
interventions. In total, over half of patients were missing at least one recommended screening, 
and on average patients were missing a third of recommended screenings. When compared to 
national averages, the low screening rates combined with existing mortality disparities and the 
established benefits of early screening demonstrate the need and potential for policy to improve 
regional preventative services use.   
i. Cervical Cancer 
Among all the studied screenings, the low screening rates for cervical cancer and proven 
effectiveness make the Pap test a priority for action. Since the introduction and the use of Pap 
testing in the 1950s, cervical cancer incidence has decreased dramatically and mortality has 
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fallen by 75 percent (20). Almost all cervical cancer incidence and mortality can be avoided with 
proper screening (20, 21). Yet, only half of RAM patients had the screening compared to 81 
percent of the national population (52). These low rates may help explain the region’s high 
incidence of cervical cancer mortality (20).  
Low cervical cancer screening use is considered a broader indicator of low health care 
access (20). The multi-level regression model selected according to AIC criteria reinforces this 
national understanding. For RAM patients, access to a personal provider and a visit to a health 
care professional all decrease the odds that a woman was missing a recommended Pap test. 
Similarly at a national level, women without a regular health care provider are less likely to 
receive a screening (56). The final regression model shows a previously undiscussed factor at the 
national level: age. Older female patients were more likely to have missed their Pap test when 
compared to younger patients. While the effect of age was small (the odds of an older woman 
missing the screening were ten percent higher than younger women) the increased odds ratio was 
significant at a 99.9 percent confidence level.  This effect could be due to the increased 
likelihood that older women had previously received a hysterectomy. Pap-tests would no longer 
be recommended for these women. Since women were not asked if they had received a 
hysterectomy, this possible bias could explain the effect of age. Regardless, the effect access to a 
personal provider and a healthcare visit in the past year indicate that policies to increase access to 
health care such as provision of health insurance could improve these screening rates. 
ii. Colorectal Cancer  
 Among RAM patients, the colorectal screening rate is 43.2 percent, just over 20 
percentage points lower than the national population (52). Again, these results should cause 
concern given both the screening’s effectiveness and the region’s existing disparity for colorectal 
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cancer mortality. Estimates show 60 percent of deaths from colorectal cancer could be prevented 
with proper screening and treatment (22). As a result, the low screening results could explain the 
region’s high rates of colorectal cancer mortality. The results from the multi-level regression do 
not provide useful information for policies to improve screening attainment. From the patient 
responses, the doctor’s office as a regular source of care increases the odds of a missed 
screening, a counterintuitive result. When this variable is removed from the model selection, 
there are no significant coefficients for patient variables. While these results do not provide a 
useful explanation of why patients are missing their colorectal screening, research at the national 
level demonstrates the importance of education, health insurance and a usual source of care (22). 
As such, policies to extend health insurance coverage could increase screening use; however, 
simple provision of insurance would not address the role of education level. These national 
findings can inform policy to improve screening rates.  
iii. Breast Cancer 
 The mammogram screening rate of 55.6 percent is a little less than 20 percentage points 
lower than the national rate of 75.2 percent (52). Women from Central Appalachia die from 
breast cancer at higher rates than the national population (20). At the national level, mammogram 
screening has likely contributed to the decrease in breast cancer mortality. Estimates attribute ten 
percent of the mortality decline from 1975-2000 to proper screening alone (23). For RAM 
patients, a previous routine check-up within the past year best predicts mammogram use. Women 
who had not had a routine checkup in the past year are almost three times more likely to have 
missed their mammogram. At the national level, health insurance has been shown to predict 
mammogram screening use, but since questions on insurance coverage were prohibited by clinic 
organizers, it is unknown whether the same holds true for RAM patients (34). Given that a 
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routine checkup is a basic indicator of healthcare access, policy changes to increase access to 
health care such as provision of health insurance could foreseeably improve these screening 
rates. 
iv. Blood Pressure and Blood Cholesterol  
Sixteen percent of patients had not had their blood pressure checked by a healthcare 
professional in the past year. Blood pressure checks are routine for almost all clinical encounters. 
As a result, the screening rate is a proxy for patients who have visited a health care professional 
in the past year. Unfortunately, no comparison to the national population is available. Thirty-
three percent of patients were not within the guidelines for blood cholesterol. Together these 
rates are unacceptably high given the region’s mortality disparity for heart disease and the utility 
of these screenings to identify at risk patients. Access to health care indicators predicted both 
screening rates. Patients without a routine checkup in the past year are more likely to miss their 
blood pressure screening while patients who listed cost as a barrier to care are more likely to 
miss their blood cholesterol screening. For both, access to a personal provider lowers the odds of 
a missed screening.  Provision of health insurance would address access to a personal provider, 
and as a result improve screening rates.   
v. Lung Cancer 
 So few RAM patients had received a lung cancer screening that all patient variables 
perfectly predict a missed screening. Just 3 of 22 previous smokers age 55-80 were screened for 
lung cancer within the past year. This result clearly indicates a need to improve screening in a 
region where patients die disproportionately from lung cancer compared to the national 
population.  
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vi. Combined Screening Indicators 
 Basic access to health care is a powerful predictor of the missed proportion of screenings.  
Patients who visited a health care professional in the past year missed a fewer proportion of 
screenings. Patients who had a routine check-up missed a fewer proportion of screenings. While 
older patients were more likely to have missed a higher percent of screenings, this result should 
be qualified with an understanding that older patients may be more likely to miss a higher 
proportion purely because they have more screenings to possibly miss. These results, in 
particular the impact of at least one visit, have important implications for policy action. The 
results suggest that having patients at least see one provider could be enough to improve overall 
adherence to preventative health measures. A policy to extend health insurance coverage would 
improve access to a personal provider, increase the likelihood of a visit with a health care 
professional and therefore improve overall screening rates.  
B. Connection to Health Care Reform  
i. Coverage under the Affordable Care Act 
 These thesis results clearly indicate the need for policy to improve preventative screening 
rates. The Affordable Care Act (ACA), passed in 2010, prioritizes preventative services to 
improve health outcomes and reduce healthcare costs. The legislation impacts preventative 
health use in two key forms.  
First, the law mandates full coverage of preventative services for private insurance plans 
and Medicare, and incentivizes full coverage for state Medicaid plans. For this thesis, health 
insurance coverage is broadly divided into three categories: private, Medicaid and Medicare. 
Private health insurance plans must provide coverage for all the preventative screenings 
addressed in this thesis with the exception of the prostate cancer screening (57). This rule 
47 
 
excludes “grandfathered” plans that existed prior to March 2010 and whose coverage policies 
have not changed significantly since then; however, it’s expected that over time all 
“grandfathered” plans will eventually lose their exempt status (57).  According to ACA 
stipulation, Medicare now provides full coverage for the studied preventative screenings, 
excluding the prostate screening. The ACA does not have the authority to require state Medicaid 
plans; however, the law incentivizes full coverage of these services by providing increased 
federal funding. Medicaid coverage differs among the four states representing RAM patients. 
Tennessee and West Virginia provide full coverage whereas Kentucky and Virginia do not (58). 
For Virginia, these screenings require three dollar copayments. In Kentucky, Medicaid does not 
require copayments for breast and cervical screenings, but does for colorectal, blood pressure 
and blood cholesterol screenings (58).  
 Second, the ACA will impact screening rates by expanding insurance coverage.  For 
RAM patients, this coverage expansion primarily occurs either through federal insurance 
subsidies and Medicaid expansion.  Both Medicaid expansion and federal health subsidies have 
extended coverage in Kentucky and West Virginia (59). For Tennessee and Virginia where 
Medicaid expansion has not occurred, a coverage gap exists for low income adults (60). Their 
income levels fall below levels for federal health subsidies but without Medicaid expansion, they 
remain uncovered.  
ii. Can rates be improved? 
These provisions of the ACA have and likely will continue to increase preventative 
screening usage for RAM patients and underserved patients of Central Appalachia. First, the 
removal of copayments for private plans and Medicare and the incentives for Medicaid plans will 
help remove remaining cost barriers for these screenings. Close to a half of patients listed that 
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cost of the screening was the reason they had not received missed screenings. Presumably, rates 
would increase for newly insured patients because this cost has almost been completely removed.  
Secondly and more importantly, ACA will improve screening rates by increasing health 
insurance coverage for these underserved patients. The Oregon Health Insurance Experiments 
provides evidence the assumption that simple provision of health insurance may be enough to 
improve use of preventative services (61). In a randomized control trial, patients who received 
Medicaid accessed the preventative screenings more than the control group for all the screenings 
relevant to this thesis with the exception of the colorectal screening. The study indicates that 
even amidst the other constraining socioeconomic conditions, including low education and 
transport barriers, insurance coverage alone is enough to improve screening rates. While 
colorectal screening rates did not improve in the Oregon study, an uptake in colorectal screening 
was observed in Massachusetts following its state health care reform in 2006 (62).  Both cases 
support my findings which highlight the importance of access to a routine provider and at least 
one health care visit within the past year for aggregated screening use. Expanded insurance 
coverage would address both factors contributing to lower screening.  
 While Medicaid expansion has not occurred in Virginia and Tennessee, federal health 
subsidies for low-income individuals would still increase insurance coverage for the region. 
Patient zip code data additionally provides anecdotal support for Medicaid expansion in both 
states. Figure 5 shows that patients are overwhelmingly from Tennessee and Virginia and there 
are few to no patients from Kentucky and West Virginia, despite the fact that Kentucky, West 
Virginia and Tennessee residents are close to equidistant from the clinic. While Kentucky and 
West Virginia have expanded Medicaid, Tennessee has not. This geographic pattern suggests 
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that Medicaid expansion would not only improve screening rates by increasing insurance 
coverage, but could lower overall demand for the RAM clinic.  
C. Role for RAM 
 Currently patients arrive at RAM with low preventative screening rates and leave with 
the same low rates because they are not utilizing the clinic’s available preventative services. 
RAM’s actions to improve the current situation can be broadly categorized into either the 
provision of screenings at the clinic or the strengthening of patient awareness of the resources 
available to receive screenings outside of RAM.  
i. Improve screening at RAM 
While the clinic does provide preventative services, only 1 in 5 patients had ever received 
a screening at any previous RAM clinic. Efforts to increase preventative service use at RAM 
could be successful given the reasons patients provided for not having a screening: unsure of 
where to receive screenings, unaware of the need for a screening or prohibited from receiving a 
screening by cost. In total, these responses were listed by close to two-thirds of RAM patients. 
Screenings at RAM would be at no cost to the patient, and effective education efforts during the 
clinic could raise awareness of the need for and availability of these screenings. With this said, 
there are two limitations to providing screenings at the RAM Wise clinic.  
First, patients primarily use the RAM clinic to receive care for acute medical, dental and 
vision concerns. It may prove too difficult to prioritize preventative services in light of these 
acute needs. Getting patients to focus on preventative service needs at the RAM clinic, could be 
related to doing the same at an emergency room or urgent care center.  
Second, there are ethical concerns on completing these screenings for patients without 
ensured access to follow-up care. Would it be appropriate to give a patient a positive result for 
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colorectal cancer knowing that at the end of the clinic they still have lack access to a health care 
provider?  This concern is partially mitigated by practices established by the University of 
Virginia Healthcare System’s Mobile Mammography Unit. Patients who need a follow-up 
appointment after their mammogram receive an appointment at the UVA Healthcare System. 
Efforts to ensure adequate follow-up care would be needed for all the screenings.  
ii. Education strategies to improve screening outside of RAM  
Even if patients continue to leave RAM without utilizing the preventative health services, 
the clinic provides an opportunity to educate patients on health care reform and its impact on the 
availability of preventative services. RAM could have the biggest impact by having trained ACA 
navigators available at the clinic to provide information on enrollment eligibility and answer 
questions concerning the online exchanges. While enrollment is not available during July when 
the clinic occurs, these navigators could still help patients prepare for the upcoming enrollment 
period in the fall. Other volunteers to educate patients on the ACA’s impact on coverage for 
preventative services could improve screening outside of the clinic. All Medicare patients should 
be reminded of the full coverage of preventative services and encouraged to take advantage of 
these free screenings. Patients with private health insurance should be reminded of the likelihood 
that their plan provides full coverage.   
Until Medicaid expansion occurs, there will continue to be a portion of the RAM patients 
for which neither Medicaid, Medicare nor private insurance practices apply. For these patients, 
RAM will continue to be a critical source not only for health care, but also for health education. 
And for close to a quarter of the patients whose sole, annual encounter with health care 
professionals is RAM, they can be made aware of the resources available for screenings. For 
women who still lack insurance coverage and fall within program guidelines, the National Breast 
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and Cervical Cancer Early Detection Program (NBCCEDP) can provide cervical and breast 
cancer screenings at no cost. The Health Wagon, a local non-profit health organization, also 
serves a community resource for these underserved patients to receive these recommended 
screenings. RAM can improve these rates by concentrated efforts to educate patients on the 
availability of these screenings through health care reform and other existing programs for 
uninsured patients.   
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VIII. Conclusion 
Low screening rates combined with the existing mortality disparities and established 
benefits of early screening demonstrate the need and potential of health care policy to improve 
regional preventative services use. The low rates observed for RAM patients matches previous 
research within the region (14, 39, 41-45). Of all the screenings, low rates for cervical, breast and 
colorectal cancer warrant policy attention given the substantial benefits of proper screening and 
the region’s mortality disparities for these cancers. Results also indicate correlations between 
low health care access variables and low screening rates. Regression model selection 
demonstrates the importance of access to a personal provider, a health care visit in the past year 
and completion of a routine checkup as predictors of screening use. Additionally, patients listed 
cost as the primary reason they had not received a preventative screening.  
These findings connect to ongoing health care reform in two key forms. First, the 
Affordable Care Act addresses the factors correlated to low screening use in this study by 
extending health insurance coverage through federal health subsidies and requiring full coverage 
for the included preventative health screenings. Second, the results support Medicaid expansion 
in Tennessee and Virginia as a way to improve preventative health. A primary goal of Medicaid 
expansion is to extend coverage in order to increase health care access and improve health 
outcomes. Results show that current preventative services use correlates to low health care 
access which may help explain the region’s existing disparities. Medicaid expansion would 
undoubtedly improve the status quo for these medically underserved patients. In addition, patient 
zip code maps show few patients from states with Medicaid expansion despite geographic 
proximity to the clinic.  
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Finally, these results provide two paths forward for the RAM clinic. First, RAM could 
prioritize getting patients screening at the clinic as long as patients remain uninsured. Currently, 
patients do not utilize the preventative services available at the clinic, and this should be 
considered a missed opportunity because for many patients RAM is their primary source of 
health care and only potential source of preventative screenings. Second, the results show the 
importance for RAM to educate patients on the impact of health care reform on preventive health 
services. Not only is RAM an opportunity for patients to learn about enrollment through the 
healthcare exchange, but patients could learn about the full coverage for preventative services 
under the law’s provisions.  
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Appendix 1: Clinic and Sample Comparison of Patients’ Zip codes 
Sample-wide: Patients Per Thousand Residents by Zip Code 
 
Clinic-Wide: Patients per Thousand Residents by Zip Code 
  
"
Patients Per Thousand Residents by Zip Code
0.01 - 0.10
0.11 - 0.33
0.34 - 1.04
1.05 - 3.10
3.11 - 9.17
Wise County Fairgrounds
"
!
Patients Per Thousand Residents by Zip Code
0.01 - 0.09
0.10 - 0.59
0.60 - 4.07
4.08 - 28.15
28.16 - 194.69
Wise County Fairgrounds
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Appendix 2: Survey Form  
Preventative Screening Use: RAM Clinic at Wise 
Date: __/__ #:  ______ Surveyor: ______ 
What is your age? ____ 
 
What would you say is your race? 
 White       Black       Hispanic       Asian       Native American   
 
What is the highest grade or year of school you completed? 
None     Elementary     Some high school     High school graduate     College 
 
What is the zip code where you live? ______ 
 
Would you say that in general your health is…? 
 Excellent      Very good       Good      Fair       Poor 
 
How many times have you been to a doctor, nurse, or other health professional in the past 
12 months? _____ 
 
How many of these visits were through Remote Area Medical (RAM), Health Wagon or a 
similar free health clinic? _____ 
 
If you saw a doctor in the last 12 months, what health concern brought you to the doctor?  
Routine checkup      Need of preventative screening       Emergency medical need     
Chronic health issue 
When you are sick or need advice about your health, to which one of the following places 
do you usually go?  
Would you say:  
Doctor's 
office 
Public 
health 
clinic  
Hospital 
outpatient 
department 
Hospital 
emergency 
room 
Urgent 
care center 
Some other 
kind of place  
No usual 
place  
 
Do you have one person you think of as your personal doctor or health care provider? 
 Yes only one      Yes more than one      No 
 
Was there a time in the past 12 months when you needed to see a doctor but could not 
because of cost? (Y/N) 
 
Have you delayed getting needed medical care for any of the following reasons in the past 
12 months? Select the most important reason.  
You couldn’t 
get through on 
the telephone. 
You couldn’t get 
an appointment 
soon enough. 
Once you got 
there, you had to 
wait too long to 
see the doctor. 
The (clinic/doctor’s) 
office wasn’t open 
when you got there. 
You didn’t have 
transportation. 
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Was there a time in the past 12 months when you did not take your medication as 
prescribed because of cost? Do not include over-the-counter (OTC) medication. (343) 
 (Y/N) 
 
DURING THE PAST 12 MONTHS, have you had your blood pressure checked by a 
doctor, nurse, or other health professional? (Y/N)  
 
DURING THE PAST 12 MONTHS, have you had your blood cholesterol checked by a 
doctor, nurse, or other health professional?  (Y/N)  
About how long has it been since you last visited a doctor for a routine checkup? A routine 
checkup is a general physical exam, not an exam for a specific injury, illness, or condition. 
Within the past year 
(anytime less than 12 
months ago) 
Within the past 2 years (1 
year  but less than 2 years 
ago) 
 Within the past 5 years (2 
years but less than 5 years 
ago) 
5 or more 
years ago 
 
Have you ever had a colonoscopy, sigmoidoscopy or fecal occult blood testing (FOBT)? 
(Colorectal cancer) [50+] (Y/N)  
 
How long has it been since you had your last fecal occult blood testing (FOBT), 
sigmoidoscopy or colonoscopy? 
1 Within the past 
year (anytime less 
than 12 months ago) 
2 Within the past 2 
years (1 year but 
less than 2 years 
ago) 
3 Within the past 3 
years (2 years but 
less than 3 years 
ago) 
4 Within the past 5 
years (3 years but 
less than 5 years 
ago) 
5 5 or 
more 
years ago 
 
A Prostate-Specific Antigen test, also called a PSA test, is a blood test used to check men 
for prostate cancer. Have you EVER HAD a PSA test? [M, 40+] (Y/N) 
 
How long has it been since you had your last PSA test? 
Within the past year 
(anytime less than 12 
months ago) 
Within the past 2 
years (1 year but 
less than 2 years 
ago) 
Within the past 3 
years (2 years but 
less than 3 years 
ago) 
Within the past 5 
years (3 years but 
less than 5 years 
ago) 
5 or 
more 
years 
ago 
 
A mammogram is an x-ray of each breast to look for breast cancer. Have you ever had a 
mammogram? [W, 40+] (Y/N) 
 
How long has it been since you had your last mammogram? 
Within the past year 
(anytime less than 12 
months ago) 
Within the past 2 
years (1 year but 
less than 2 years 
ago) 
Within the past 3 
years (2 years but 
less than 3 years 
ago) 
Within the past 5 
years (3 years but 
less than 5 years 
ago) 
5 or 
more 
years 
ago 
 
A Pap test is a test for cancer of the cervix. Have you ever had a Pap test? [W, 21-65] (Y/N) 
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How long has it been since you had your last Pap test? 
Within the past year 
(anytime less than 12 
months ago) 
Within the past 2 
years (1 year but 
less than 2 years 
ago) 
Within the past 3 
years (2 years but 
less than 3 years 
ago) 
Within the past 5 
years (3 years but 
less than 5 years 
ago) 
5 or 
more 
years 
ago 
 
Do you currently smoke or have you quit smoking within the past 15 years?  (Y/N) 
 
Have you ever had a screening for lung cancer? [55-80] (Y/N) 
 
How long has it been since you were last screened for lung cancer?  
Within the past year 
(anytime less than 12 
months ago) 
Within the past 2 
years (1 year but 
less than 2 years 
ago) 
Within the past 3 
years (2 years but 
less than 3 years 
ago) 
Within the past 5 
years (3 years but 
less than 5 years 
ago) 
5 or 
more 
years 
ago 
 
Did you not receive one of the above screenings or routine check-up for any of the following 
reasons? 
Cost 
 
   Unaware the 
screening    was 
needed 
Did not think the 
screening was worth the 
cost 
Unsure of where to 
receive the screening 
Travel distance to 
receive the screening 
 
Did you receive any of these preventative screenings at a RAM clinic?  (Y/N)  
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Appendix 3: Interview Question Source & USPTF Recommendation  
Number Question Source USPTF Recommendation 
1 What is your age? BRFSS NA 
2 
Gender. Not asked 
directly but determined 
by interview responses.  NA NA 
3 
What would you say is 
your race? NA NA 
4 
What is the highest 
grade or year of school 
you completed? BRFSS NA 
5 
What is the zip code 
where you live? BRFSS NA 
6 
Would you say that in 
general your health is— BRFSS NA 
7 
How many times have 
you been to a doctor, 
nurse, or other health 
professional in the past 
12 months? BRFSS NA 
8 
How many of these 
visits were through 
Remote Area Medical 
(RAM), Health Wagon 
or a similar free health 
clinic? BRFSS NA 
9 
If you saw a doctor in 
the last 12 months, what 
health concern brought 
you to the doctor? 
(Primary, Secondary) Project NA 
10 
When you are sick or 
need advice about your 
health, to which one of 
the following places do 
you usually go? Would 
you say: a doctor's 
office, a public health 
clinic or community 
health center, a hospital 
outpatient department, a 
hospital emergency 
room, urgent care 
center, some other kind 
of place, or no usual 
place? BRFSS NA 
11 
Do you have one person 
you think of as your 
personal doctor or 
health care provider? BRFSS NA 
12 
Was there a time in the 
past 12 months when 
you needed to see a 
doctor but could not 
because of cost? BRFSS NA 
13 
Have you delayed 
getting needed medical 
care for any of the 
following reasons in the 
past 12 months? Select 
the most important 
reason. BRFSS NA 
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14 
Was there a time in the 
past 12 months when 
you did not take your 
medication as 
prescribed because of 
cost? Do not include 
over-the-counter (OTC) 
medication. (343) BRFSS NA 
15 
DURING THE PAST 
12 MONTHS, have you 
had your blood pressure 
checked by a doctor, 
nurse, or other health 
professional? BRFSS 
18+. Evidence is lacking to recommend an optimal interval for 
screening adults for hypertension. "For adults age 18 or older. There 
is no evidence on which to base a recommendation for optimal 
interval. The Joint National Committee on Prevention Diagnosis and 
Treatment of High Blood Pressure recommends every 2 years in 
persons w/ initial BP < 120/80 and every year in persons with BP 
120-139 or diastolic 80-89. VA/DoD guideline (2004) recommends 
annual" http://www.ncbi.nlm.nih.gov/books/NBK82767/ 
16 
DURING THE PAST 
12 MONTHS, have you 
had your blood 
cholesterol checked by 
a doctor, nurse, or other 
health professional? BRFSS 
The U.S. Preventive Services Task Force (USPSTF) strongly 
recommends screening men aged 35 and older for lipid disorders, 
The USPSTF strongly recommends screening women aged 45 and 
older for lipid disorders if they are at increased risk for coronary heart 
disease. 
17 
About how long has it 
been since you last 
visited a doctor for a 
routine checkup? A 
routine checkup is a 
general physical exam, 
not an exam for a 
specific injury, illness, 
or condition. NHIS No recommendation.  
18 
Have you ever had a 
colonoscopy, 
sigmoidiscopy or fecal 
occult blood testing 
(FOBT)? [Colorectal 
cancer, 50+] NHIS 
Annual screening with high-sensitivity fecal occult blood testing, 
Sigmoidoscopy every 5 years, with high-sensitivity fecal occult blood 
testing every 3 years, Screening colonoscopy every 10 years 
19 
How long has it been 
since you had your last 
fecal occult blood 
testing (FOBT), 
sigmoidoscopy or 
colonoscopy? BRFSS 
Annual screening with high-sensitivity fecal occult blood testing, 
Sigmoidoscopy every 5 years, with high-sensitivity fecal occult blood 
testing every 3 years, Screening colonoscopy every 10 years 
20 
A Prostate-Specific 
Antigen test, also called 
a PSA test, is a blood 
test used to check men 
for prostate cancer. 
Have you EVER HAD a 
PSA test? BRFSS No longer recommended by USPTF 
21 
How long has it been 
since you had your last 
PSA test? BRFSS No longer recommended by USPTF 
22 
A mammogram is an x-
ray of each breast to 
look for breast cancer. 
Have you ever had a 
mammogram? BRFSS 40-50 per patient. 50-75 every 2 years 
23 
How long has it been 
since you had your last 
mammogram? BRFSS 40-50 per patient. 50-75 every 2 years 
24 
A Pap test is a test for 
cancer of the cervix. 
Have you ever had a 
Pap test? BRFSS 
21-65 every 3 years.recommends against screening for cervical 
cancer in women who have had a hysterectomy with removal of the 
cervix 
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25 
How long has it been 
since you had your last 
Pap test? BRFSS 
21-65 every 3 years. Recommends against screening for cervical 
cancer in women who have had a hysterectomy with removal of the 
cervix 
26 
Do you currently smoke 
or have you quit 
smoking in the past 15 
years? Project NA 
27 
Have you ever had a 
screening for lung 
cancer? (55-80) Project 
annual screening for lung cancer with low-dose computed 
tomography (LDCT) in adults aged 55 to 80 years who have a 30 
pack-year smoking history and currently smoke or have quit within 
the past 15 years 
28 
How long has it been 
since you were last 
screened for lung 
cancer? Project 
annual screening for lung cancer with low-dose computed 
tomography (LDCT) in adults aged 55 to 80 years who have a 30 
pack-year smoking history and currently smoke or have quit within 
the past 15 years 
29 
Did you not receive one 
of the above screenings 
or routine check up for 
any of the following 
reasons? Project NA 
30 
Did you receive any of 
these preventative 
screenings at a RAM 
clinic? Project NA 
 
 
 
